TTX-DM1

N/A

Report date: 2025/01/26 15:57:00
NME

Base Information

Drug NameTTX-DM1
Drug Alias Nameoligonucleotide therapy (Triplet Therapeutics)TTX-DM1
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionDNA mismatch repair protein Msh3 inhibitors
TargetsDNA mismatch repair protein Msh3
Therapy Area/IndicationsMyotonic Dystrophy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTriplet Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesTriplet Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsMyotonic Dystrophy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A